Treace Medical Concepts Inc (TMCI)
6.90 +0.18 (+2.68%) 04/28/25 [NASDAQ]
2.79 x 100 10.97 x 100
Realtime by (Cboe BZX)
2.79 x 100 10.97 x 100
Realtime - - (-) -
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -55,743 | -49,527 | -42,815 | -20,552 | -3,668 |
Depreciation Amortization | 7,572 | 4,243 | 2,251 | 861 | 1,430 |
Accounts receivable | -5,687 | -9,301 | -11,039 | -4,226 | -4,290 |
Accounts payable and accrued liabilities | -1,313 | 3,167 | 4,612 | 1,791 | 1,334 |
Other Working Capital | -25,530 | -9,783 | -5,809 | -983 | -4,174 |
Other Operating Activity | 43,534 | 26,626 | 22,152 | 5,916 | 4,874 |
Operating Cash Flow | $-37,167 | $-34,575 | $-30,648 | $-17,193 | $-4,494 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 46,968 | -49,841 | -61,680 | N/A | N/A |
PPE Investments | -11,593 | -11,458 | -14,838 | -2,705 | -1,069 |
Net Acquisitions | N/A | -20,000 | N/A | N/A | N/A |
Investing Cash Flow | $35,375 | $-81,299 | $-76,518 | $-2,705 | $-1,069 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | 3,850 | N/A | N/A |
Debt Issued | N/A | N/A | 49,651 | N/A | 31,318 |
Debt Repayment | N/A | N/A | -33,893 | -1,788 | -20,000 |
Common Stock Issued | 428 | 109,396 | 2,187 | 109,440 | 364 |
Other Financing Activity | -268 | -13 | -989 | 0 | -179 |
Financing Cash Flow | $160 | $109,383 | $20,806 | $107,652 | $11,503 |
Beginning Cash Position | 12,982 | 19,473 | 105,833 | 18,079 | 12,139 |
End Cash Position | 11,350 | 12,982 | 19,473 | 105,833 | 18,079 |
Net Cash Flow | $-1,632 | $-6,491 | $-86,360 | $87,754 | $5,940 |
Free Cash Flow | |||||
Operating Cash Flow | -37,167 | -34,575 | -30,648 | -17,193 | -4,494 |
Capital Expenditure | -11,593 | -11,458 | -14,838 | -2,705 | -1,069 |
Free Cash Flow | -48,760 | -46,033 | -45,486 | -19,898 | -5,563 |